Integrin-Blocking Antibodies Delay Keratinocyte Re-Epithelialization in a Human Three-Dimensional Wound Healing Model
Open Access
- 21 May 2010
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 5 (5), e10528
- https://doi.org/10.1371/journal.pone.0010528
Abstract
The α6β4 integrin plays a significant role in tumor growth, angiogenesis and metastasis through modulation of growth factor signaling, and is a potentially important therapeutic target. However, α6β4-mediated cell-matrix adhesion is critical in normal keratinocyte attachment, signaling and anchorage to the basement membrane through its interaction with laminin-5, raising potential risks for targeted therapy. Bioengineered Human Skin Equivalent (HSE), which have been shown to mimic their normal and wounded counterparts, have been used here to investigate the consequences of targeting β4 to establish toxic effects on normal tissue homeostasis and epithelial wound repair. We tested two antibodies directed to different β4 epitopes, one adhesion-blocking (ASC-8) and one non-adhesion blocking (ASC-3), and determined that these antibodies were appropriately localized to the basal surface of keratinocytes at the basement membrane interface where β4 is expressed. While normal tissue architecture was not altered, ASC-8 induced a sub-basal split at the basement membrane in non-wounded tissue. In addition, wound closure was significantly inhibited by ASC-8, but not by ASC-3, as the epithelial tongue only covered 40 percent of the wound area at 120 hours post-wounding. These results demonstrate β4 adhesion-blocking antibodies may have adverse effects on normal tissue, whereas antibodies directed to other epitopes may provide safer alternatives for therapy. Taken together, we conclude that these three-dimensional tissue models provide a biologically relevant platform to identify toxic effects induced by candidate therapeutics, which will allow generation of findings that are more predictive of in vivo responses early in the drug development process.This publication has 29 references indexed in Scilit:
- Translating tissue engineering technology platforms into cancer researchJournal of Cellular and Molecular Medicine, 2009
- Assuring consumer safety without animalsOrganogenesis, 2009
- Three‐Dimensional Tissue Models of Normal and Diseased SkinCurrent Protocols in Cell Biology, 2008
- The basement membrane microenvironment directs the normalization and survival of bioengineered human skin equivalentsMatrix Biology, 2008
- Multiple Functions of the Integrin α6β4 in Epidermal Homeostasis and TumorigenesisMolecular and Cellular Biology, 2006
- Mobilization and activation of a signaling competent α6β4integrin underlies its contribution to carcinoma progressionCancer and Metastasis Reviews, 2005
- Integrin signalling during tumour progressionNature Reviews Molecular Cell Biology, 2004
- Integrins: Bidirectional, Allosteric Signaling MachinesCell, 2002
- Metastatic growth of squamous cell carcinomas is correlated with upregulation and redistribution of hemidesmosomal componentsCell and tissue research, 2001
- Cooperative Signaling between α6β4Integrin and ErbB-2 Receptor Is Required to Promote Phosphatidylinositol 3-Kinase-dependent InvasionOnline Journal of Public Health Informatics, 2000